$195.09
-0.94-0.48%
At close: Sep 25, 5:00 PM EST
$195.09
N/A
After Hours: Sep 25, 4:00 PM EST
Axsome Therapeutics Inc
AXSMNASDAQ
Axsome Therapeutics Earnings & Forecasts
Axsome Therapeutics (AXSM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Axsome Therapeutics Guidance
Axsome Therapeutics (AXSM) last issued guidance on January 4, 2024 for fiscal year 2023. The company guided revenue in the range of $204M - $204M for the period.
Compared to prior guidance, Axsome Therapeutics raised its revenue forecast from a prior range of $71M - $71M.
Axsome Therapeutics has issued 2 guidance updates between January 4, 2024 and January 4, 2024. During this period, the company raised its outlook 1 time, reflecting management's growing confidence in business performance.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.87 | $-0.83 | $-0.72 | $-0.87 |
| Actual | $-0.99 | $-1.26 | $-0.56 | $-0.68 |
| Surprise | -13.8% | -51.8% | +22.2% | +21.8% |
| Revenue | ||||
| Estimate | $222.3M | $190.3M | $193.2M | $163.4M |
| Actual | $218.4M | $191.2M | $196.0M | $171.0M |
| Surprise | -1.77% | +0.48% | +1.47% | +4.64% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.49 | $0.02 | $-0.08 | $0.49 |
| Revenue | ||||
| Consensus | $257.5M | $296.5M | — | — |
